CORT — Corcept Therapeutics

Median target
$162.5
calls from the last 12 months
Implied return
+98.3%
median target vs. price
Coverage
7 analysts · 8 calls
updated in the last 12 months
Consensus
6/0/1+5 net
Buy / Hold / Sell

Which analysts are behind CORT's consensus?

See every current rating, price target and the analysts' track records for Corcept Therapeutics — plus the full analyst rankings, firm analytics and screener.

The consensus above reflects 7 analysts with calls on CORT updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.

CORT elsewhere on AnalystEdge

The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.

Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)

DateSourceWhoActionDetailAmount
2026-11-03InsidersMaduck SeanInsider sale8.6K sh @ $82.02 · planned trade$707K
2026-11-03InsidersMaduck SeanInsider sale4.5K sh @ $82.68 · planned trade$376K
2026-11-02InsidersMaduck SeanInsider sale11.8K sh @ $81.42 · planned trade$964K
2026-11-02InsidersVieira Roberto WandenkolkPresident, OncologyInsider sale6.7K sh @ $80.73 · planned trade$537K
2026-11-02InsidersVieira Roberto WandenkolkPresident, OncologyInsider sale1.7K sh @ $81.52 · planned trade$137K
2026-10-15InsidersWilson James NDirectorInsider sale6.7K sh @ $114.48 · planned trade$762K
2026-10-15InsidersWilson James NDirectorInsider sale3.0K sh @ $115.39 · planned trade$351K
2026-10-15InsidersWilson James NDirectorInsider sale300 sh @ $116.30 · planned trade$35K
2026-10-02InsidersMaduck SeanSee RemarksInsider sale15.8K sh @ $116.12 · planned trade$1.8M
2026-10-02InsidersMaduck SeanSee RemarksInsider sale8.7K sh @ $116.55 · planned trade$1.0M

More: insider activity · executive branch · trending